레이저 캡처 미세 절제술(LCM) : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the laser capture microdissection market size is expected to grow from USD 202.99 million in 2025 to USD 223.17 million in 2026 and is forecast to reach USD 358.43 million by 2031 at 9.94% CAGR over 2026-2031.

This report is Segmented by Product (Instruments, and More), System Type (Ultraviolet LCM, and More), Application (Research & Development [Genomics, Proteomics], and More), End User (Academic & Government Research Institutes, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Laser Capture Microdissection Market Trends and Insights

Rising Public & Private-Sector R&D Outlays in Oncology & Neurology

Cancer and neurodegenerative disease burdens spur funding streams that make laser capture microdissection a staple in academic and commercial labs. Chinese and Japanese grants bankroll national spatial-omics hubs that rely on the technique for single-cell genomics. Each oncology project typically loops laser capture microdissection into several stages, from tumor microenvironment mapping to therapy monitoring. The requirement now reads as table stakes for competitive drug pipelines, causing pharmaceutical sponsors to specify laser capture microdissection in research contracts. This steady cash flow underpins long-term growth prospects in every major region.

Technical Advantages Vs. Manual Microdissection

Laser capture microdissection produces contamination-free sections with consistent success, unlike manual scalpel methods that risk cross-talk between adjacent cells. Preservation of RNA integrity matters when labs shift toward single-cell transcriptomics requiring intact molecules. Automation removes operator bias and improves reproducibility, reducing costly re-runs. Imaging modules help scientists identify cell clusters by morphology or fluorescence at sub-cellular resolution, enabling studies in developmental biology and disease progression once impossible with manual extraction. These combined benefits shorten workflow times and raise confidence in downstream analytics.

High Capital & Maintenance Cost of Integrated Systems

Full laser capture microdissection workstations often top USD 500,000, placing them beyond reach for many mid-tier labs. Annual service contracts reach 15-20% of purchase value, covering laser calibration and optics replacement. Limited budgets force institutions to share core facilities, stretching booking schedules and lowering throughput. Emerging-market universities find procurement cycles lengthy, delaying installations that could support grant competitiveness. Even in wealthier regions, budget reallocations toward consumables and data analysis sometimes slow new equipment orders.

Other drivers and restraints analyzed in the detailed report include:

1. Surge in Spatial-Omics & Single-Cell Multi-Omics Workflows
2. Growth in Precision-Medicine Biomarker Discovery Programs
3. Shortage of Pathologists & Trained Technologists in Histology Labs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Consumables are the fastest rising category, projected to climb at a 13.03% CAGR through 2031 as high-throughput pipelines require continuous supplies of capture films, slides, and reagents. Instruments retained a 44.05% laser capture microdissection market share in 2025, yet the shift to subscription-style ordering models signals a maturing buyer base focused on long-term workflow consistency. Software & services, though smaller in sales, gain relevance as buyers seek turnkey ecosystems that link microdissection hardware to downstream sequencing and bioinformatics.

This transition widens profit pools by anchoring vendors to installed bases through steady consumable demand. Novel polymer membranes now tailor adhesion and thickness to specific tissue classes, improving capture efficiency. Suppliers add RFID tags to consumables so laboratories can track batch usage and automate re-ordering. As microfluidic-LCM hybrids reach market, entirely new cartridge formats could deliver combined isolation and lysis, enabling bundled revenue streams that blur the boundary between hardware and consumables.

Ultraviolet systems owned 51.51% revenue in 2025, yet infrared platforms are forecast to expand 15.17% yearly thanks to milder thermal signatures that protect DNA and proteins for downstream omics. Infrared devices also capture cells more cleanly, which suits single-cell pipelines seeking error-free libraries. UV systems remain popular where morphological preservation is essential, such as teaching hospitals that pair microdissection with conventional histology.

Vendors differentiate through automation depth, sample navigation speed, and compatibility with high-content image analysis. Infrared platforms operate at lower power thresholds that cut edge carbonization, enhancing capture yield. Meanwhile, laser microdissection pressure-catapulting systems find niche demand in forensic science, where non-contact ejection eliminates contamination risk in trace DNA work. Together these advances keep the laser capture microdissection market responsive to shifting research priorities.

Complete Report Scope:

• By Product
  • Instruments
  • Consumables
  • Software & Services
• By System Type
  • Ultraviolet LCM
  • Infrared LCM
  • Immunofluorescence-guided LCM
  • LMPC (Laser Microdissection Pressure-Catapulting)
• By Application
  • Research & Development
    • Genomics
    • Proteomics
  • Diagnostics
    • Oncology
    • Pathology and Cytopathology
  • Forensics & Others
• By End User
  • Academic & Government Research Institutes
  • Hospitals
  • Pharmaceutical, Biotechology Companies & CROs
  • Forensic Science Laboratories
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained 42.42% of laser capture microdissection market share in 2025, supported by sustained National Institutes of Health funding and mature pharmaceutical R&D clusters. Widespread adoption of digital pathology simplifies workflow integration, while AI-assisted microdissection reduces labor bottlenecks. Nevertheless, staffing shortages and reimbursement pressures temper near-term growth.

Europe follows as the second-largest region through concerted public-private programs that back precision-medicine research. Germany, the United Kingdom, and France house multiple laser capture microdissection core facilities that operate as shared hubs, improving equipment utilization. Harmonized companion diagnostic regulations encourage device makers to partner with local biopharma companies. Still, funding variability among EU states and post-Brexit research uncertainties create uneven adoption rates across the continent.

Asia-Pacific posts the fastest 13.19% CAGR to 2031. China's Five-Year Plan prioritizes spatial biology, prompting large-scale laboratory construction and bulk purchasing agreements. Japanese institutes pursue oncology and neurodegeneration studies that depend on high-fidelity infrared microdissection. India's contract research organizations add laser capture microdissection to service menus for global drug sponsors, yet infrastructure gaps and talent shortages may slow rollout outside tier-one cities. Collective investment across the region points to sustained, above-average expansion.

1. Carl Zeiss
2. Danaher Corp (Leica Microsystems)
3. Thermo Fisher Scientific
4. Molecular Machines & Industries
5. Fluidigm Corp.
6. LLS Rowiak LaserLabSolutions GmbH
7. Molecular Devices
8. Hamilton Thorne
9. Motic Instruments Inc.
10. MicroSupport Co. Ltd.
11. Epistem Ltd.
12. VitroVivo Biotech LLC
13. Caresbio Laboratory
14. GnomeDX LLC
15. Biogenity Ltd.
16. PALM MicroBeam
17. Tecan Group
18. Omnit Labs
19. AvanSci Bio
20. NIKON Instruments Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Public & Private-Sector R&D Outlays in Oncology & Neurology
  • 4.2.2 Technical Advantages Vs. Manual Microdissection
  • 4.2.3 Surge in Spatial-Omics & Single-Cell Multi-Omics Workflows
  • 4.2.4 Growth in Precision-Medicine Biomarker Discovery Programs
  • 4.2.5 AI-Guided Image Recognition Enabling Fully Automated LCM
  • 4.2.6 Emergence of Microfluidic-LCM Hybrids for High-Throughput Sample Prep
• 4.3 Market Restraints
  • 4.3.1 High Capital & Maintenance Cost of Integrated Systems
  • 4.3.2 Shortage of Pathologists & Trained Technologists in Histology Labs
  • 4.3.3 Thermal / UV-Induced Nucleic-Acid Damage Risk in Delicate Samples
  • 4.3.4 Competition From Droplet-Based Single-Cell Isolation Platforms
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitutes
  • 4.4.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Product
  • 5.1.1 Instruments
  • 5.1.2 Consumables
  • 5.1.3 Software & Services
• 5.2 By System Type
  • 5.2.1 Ultraviolet LCM
  • 5.2.2 Infrared LCM
  • 5.2.3 Immunofluorescence-guided LCM
  • 5.2.4 LMPC (Laser Microdissection Pressure-Catapulting)
• 5.3 By Application
  • 5.3.1 Research & Development
    • 5.3.1.1 Genomics
    • 5.3.1.2 Proteomics
  • 5.3.2 Diagnostics
    • 5.3.2.1 Oncology
    • 5.3.2.2 Pathology and Cytopathology
  • 5.3.3 Forensics & Others
• 5.4 By End User
  • 5.4.1 Academic & Government Research Institutes
  • 5.4.2 Hospitals
  • 5.4.3 Pharmaceutical, Biotechology Companies & CROs
  • 5.4.4 Forensic Science Laboratories
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Carl Zeiss Meditec AG
  • 6.3.2 Danaher Corp (Leica Microsystems)
  • 6.3.3 Thermo Fisher Scientific Inc.
  • 6.3.4 Molecular Machines & Industries GmbH
  • 6.3.5 Fluidigm Corp.
  • 6.3.6 LLS Rowiak LaserLabSolutions GmbH
  • 6.3.7 Molecular Devices LLC
  • 6.3.8 Hamilton Thorne Inc.
  • 6.3.9 Motic Instruments Inc.
  • 6.3.10 MicroSupport Co. Ltd.
  • 6.3.11 Epistem Ltd.
  • 6.3.12 VitroVivo Biotech LLC
  • 6.3.13 Caresbio Laboratory LLC
  • 6.3.14 GnomeDX LLC
  • 6.3.15 Biogenity Ltd.
  • 6.3.16 PALM MicroBeam
  • 6.3.17 Tecan Group Ltd.
  • 6.3.18 Omnit Labs
  • 6.3.19 AvanSci Bio
  • 6.3.20 NIKON Instruments Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment